Stay updated on M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial page.

Latest updates to the M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe study details page shows updated core content, including revised eligibility criteria and listed locations.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page shows a new revision label, changing from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check45 days agoChange DetectedThe participating locations list has been updated with additions and removals across multiple sites and countries.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded: Show glossary feature; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 Monotherapy in 2L Biliary Tract Cancer Clinical Trial page.